SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-024683
Filing Date
2022-11-14
Accepted
2022-11-14 07:20:31
Documents
70
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q cgem-20220930.htm   iXBRL 10-Q 2886851
2 EX-31.1 cgem-ex31_1.htm EX-31.1 18542
3 EX-31.2 cgem-ex31_2.htm EX-31.2 18271
4 EX-32.1 cgem-ex32_1.htm EX-32.1 18388
  Complete submission text file 0000950170-22-024683.txt   9842713

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cgem-20220930_def.xml EX-101.DEF 160649
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cgem-20220930.xsd EX-101.SCH 65866
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cgem-20220930_lab.xml EX-101.LAB 451303
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cgem-20220930_cal.xml EX-101.CAL 44905
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cgem-20220930_pre.xml EX-101.PRE 323390
64 EXTRACTED XBRL INSTANCE DOCUMENT cgem-20220930_htm.xml XML 2061607
Mailing Address ONE MAIN STREET SUITE 1350 CAMBRIDGE MA 02142
Business Address ONE MAIN STREET SUITE 1350 CAMBRIDGE MA 02142 617-410-4650
Cullinan Oncology, Inc. (Filer) CIK: 0001789972 (see all company filings)

IRS No.: 813867811 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39856 | Film No.: 221380196
SIC: 2836 Biological Products, (No Diagnostic Substances)